| ||
FDA approves Teva's generic version of blood thinner Plavix Globes Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) has obtained US Food and Drug Administration (FDA) approval for its generic version of the blood thinner Plavix (clopidogrel bisulfate). The drug helps reduce the risk of heart attack and ... See all stories on this topic » | ||
Turning from heroin to meth, drug cartels in South Asia find prime conditions ... Washington Post This environment has allowed criminals to tap into the countries' relatively advanced pharmaceutical industries to get their hands on meth's two main ingredients: ephedrine and pseudoephedrine. The drug is more valuable than heroin, and some say, ... See all stories on this topic » | ||
Cobiprostone Preclinical Data from NSAID-Induced Gastric Mucosal Injury Models ... MarketWatch (press release) BETHESDA, Md., May 20, 2012 (BUSINESS WIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced the presentation of preclinical data at Digestive Disease Week 2012, in San Diego, which demonstrates the protective effect of cobiprostone (also ... See all stories on this topic » | ||
First China Pharma Announces Unaudited Financials and Issues Guidance for Q1 2012 Healthcare Global (press release) KUNMING, CHINA--(Marketwire - May 18, 2012) - First China Pharmaceutical Group, Inc. ( OTCBB : FCPG ) ("First China" or the "Company"), a rapidly growing and technologically advanced pharmaceutical distribution company based in Yunnan, China, ... See all stories on this topic » | ||
Teva's board reelects Phillip Frost as chairman Globes Teva Pharmaceutical Industries' (Nasdaq: TEVA; TASE: TEVA) board of directors unanimously reelected Philip Frost as chairman late Thursday for a second three-year term. Teva's shareholders will have to approve the appointment at the upcoming general ... See all stories on this topic » | ||
The big comeback: The Globe 100 returns to full strength Boston Globe A few in the pharmaceutical or biotech industries broke through to sustained profitability after years of losses developing products. Momenta falls into that category, as does Dusa Pharmaceuticals Inc. of Wilmington. Big companies with familiar old ... See all stories on this topic » | ||
Smugglers find new route to sneak drugs into Myanmar Times of India The illegal pharmaceutical substance business has found a new market in the Myanmarese border of Manipur, said a customs official. According to intelligence sources, the drug peddlers of the region have been constantly using two routes- the ... See all stories on this topic » | ||
Report: Clinical trials create economic windfall in Md. WTOP Now, a study by a pharmaceutical industry group concludes that bio-pharmaceutical companies are helping support 81000 jobs in Maryland. The study says Maryland has hosted 3500 clinical drug trials since 1999. Most of the trials take place in Baltimore ... See all stories on this topic » | ||
|
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment